Editorial policies of pediatric journals: Survey of instructions for authors

Archives of Pediatrics and Adolescent Medicine

Volumn 164, Issue 3, 2010, Pages 268-272

  Meerpohl, Joerg J ^a   Wolff, Robert F ^a,b   Niemeyer, Charlotte M ^a   Antes, Gerd ^a   Von Elm, Erik ^a,c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b KLEIJNEN SYSTEMATIC REVIEWS LTD   (United Kingdom)

^c SWISS PARAPLEGIC RESEARCH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; MEDICAL LITERATURE; MEDICAL SOCIETY; PRIORITY JOURNAL; PUBLICATION; CLINICAL TRIAL; CONFLICT OF INTEREST; HUMAN; INTERNATIONAL COOPERATION; PEDIATRICS; PRACTICE GUIDELINE; PUBLISHING; RESEARCH ETHICS; STANDARD; STATISTICS; WRITING;

AUTHORSHIP; CLINICAL TRIALS AS TOPIC; CONFLICT OF INTEREST; EDITORIAL POLICIES; ETHICS, RESEARCH; GUIDELINE ADHERENCE; GUIDELINES AS TOPIC; HUMANS; INTERNATIONALITY; JOURNALISM, MEDICAL; PEDIATRICS; PERIODICALS AS TOPIC;

EID: 77950265838     PISSN: 10724710     EISSN: 15383628     Source Type: Journal    
DOI: 10.1001/archpediatrics.2009.287     Document Type: Article

References (40)

1. Dwan K, Altman DG, Arnaiz JA, et al. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One. 2008;3(8):e3081.
2. Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA. 2003;289(4):454-465.
3. Titus SL, Wells JA, Rhoades LJ. Repairing research integrity. Nature. 2008;453 (7198):980-982.
4. Hetherington J, Dickersin K, Chalmers I, Meinert CL. Retrospective and prospective identification of unpublished controlled trials: lessons from a survey of obstetricians and pediatricians. Pediatrics. 1989;84(2):374-380.
5. Uniform requirements for manuscripts submitted to biomedical journals: writing and editing for biomedical publication. International Committee of Medical Journal Editors Web site. www.icmje.org. Accessed August 6, 2008.
6. Journals following URM. International Committee of Medical Journal Editors Web site. www.icmje.org/journals.html. Accessed August 8, 2008.
7. Plint AC, Moher D, Morrison A, et al. Does the CONSORT checklist improve the quality of reports of randomised controlled trials? a systematic review. Med J Aust. 2006;185(5):263-267.
8. Smith R. Beyond conflict of interest: transparency is the key. BMJ. 1998;317(7154):291-292.
9. Bhargava N, Qureshi J, Vakil N. Funding source and conflict of interest disclosures by authors and editors in gastroenterology specialty journals. Am J Gastroenterol. 2007;102(6):1146-1150.
10. Stelfox HT, Chua G, O'Rourke K, Detsky AS. Conflict of interest in the debate over calcium-channel antagonists. N Engl J Med. 1998;338(2):101-106.
11. De Angelis C, Drazen JM, Frizelle FA, et al; International Committee of Medical Journal Editors. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Croat Med J. 2004;45(5):531-532.
12. Bonati M, Pandolfini C. Trial registration, the ICMJE statement, and paediatric journals. Arch Dis Child. 2006;91(1):93.
13. Rivara FP. Registration of clinical trials. Arch Pediatr Adolesc Med. 2005;159(7):685.
14. Gülmezoglu AM, Pang T, Horton R, Dickersin K. WHO facilitates international collaboration in setting standards for clinical trial registration. Lancet. 2005;365(9474):1829-1831.
15. Journal Citation Report 2007. ISI Web of Knowledge Web site. http://admin-apps.isiknowledge.com/JCR/JCR?SID=R2bkeAaboDlmaDaHaOm. Accessed August 5, 2008.
16. Moher D, Schulz KF, Altman D; CONSORT Group (Consolidated Standards of Reporting Trials). The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA. 2001;285 (15):1987-1991.
17. Altman DG, Schulz KF, Moher D, et al; CONSORT GROUP (Consolidated Standards of Reporting Trials). The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001;134(8):663-694.
18. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147(8):573-577.
19. Vandenbroucke JP, von Elm E, Altman DG, et al; STROBE initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med. 2007;147(8):W163-94.
20. Bossuyt PM, Reitsma JB, Bruns DE, et al; Standards for Reporting of Diagnostic Accuracy. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD Initiative. Ann Intern Med. 2003;138(1):40-44.
21. Bossuyt PM, Reitsma JB, Bruns DE, et al; Standards for Reporting of Diagnostic Accuracy. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med. 2003;138(1):W1-12.
22. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008- 2012.
23. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. quality of reporting of meta-analyses. Lancet. 1999;354(9193):1896- 1900.
24. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535. doi:10.1136/bmj.b2535.
25. Garfield E. The history and meaning of the journal impact factor. JAMA. 2006;295(1):90-93.
26. Hopewell S, Altman DG, Moher D, Schulz KF. Endorsement of the CONSORT statement by high impact factor medical journals: a survey of journal editors and journal 'Instructions to Authors'. Trials. 2008;9(1):20.
27. Schriger DL, Arora S, Altman DG. The content of medical journal instructions for authors. Ann Emerg Med. 2006;48(6):743-749, 749. e1-e4.
28. Matarese V. Relationship between quality and editorial leadership of biomedical research journals: a comparative study of Italian and UK journals. PLoS One. 2008;3(7):e2512.
29. Bonati M, Impicciatore P, Pandolfini C. Registering clinical trials: register of clinical trials in children must be set up. BMJ. 2000;320(7245):1339-1340.
30. Pandolfini C, Bonati M, Rossi V, et al. The DEC-net European register of paediatric drug therapy trials: contents and context. Eur J Clin Pharmacol. 2008;64(6):611-617.
31. Santoro E, Rossi V, Pandolfini C, Bonati M. DEC-net: the development of the European register of clinical trials on medicines for children. Clin Trials. 2006;3(4):366-375.
32. Sim I, Chan AW, Gulmezoglu AM, Evans T, Pang T. Clinical trial registration: transparency is the watchword. Lancet. 2006;367(9523):1631-1633.
33. Zarin DA, Ide NC, Tse T, Harlan WR, West JC, Lindberg DA. Issues in the registration of clinical trials. JAMA. 2007;297(19):2112-2120.
34. Dulai SK, Slobogean BL, Beauchamp RD, Mulpuri K. A quality assessment of randomized clinical trials in pediatric orthopaedics. J Pediatr Orthop. 2007;27(5):573-581.
35. Raad JM, Bellinger S, McCormick E, Roberts MC, Steele RG. Brief report: reporting practices of methodological information in four journals of pediatric and child psychology. J Pediatr Psychol. 2008;33(7):688-693.
36. Standing JF, Khaki ZF, Wong IC. Poor formulation information in published pediatric drug trials. Pediatrics. 2005;116(4):e559-e562.
37. Welk B, Afshar K, MacNeily AE. Randomized controlled trials in pediatric urology: room for improvement. J Urol. 2006;176(1):306-309, discussion 309-310.
38. Moher D, Jones A, Lepage L; CONSORT Group (Consolitdated Standards for Reporting of Trials). Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. JAMA. 2001;285(15):1992-1995.
39. Dong P, Loh M, Mondry A. The "impact factor" revisited. Biomed Digit Libr. 2005;2:7.
40. Hernán MA. Impact factor: a call to reason. Epidemiology. 2009;20(3):317-318, discussion 319-320.